Expression Profiles of DNA Methylation and Demethylation Machinery Components in Pediatric Myelodysplastic Syndrome: Clinical Implications

Autor: Lamim Lovatel V, de Souza Fernandez C, Ferreira Rodrigues E, de Cassia Tavares R, Sobral da Costa E, Abdelhay E, Coelho Soares Lima S, de Souza Fernandez T

Publikováno v: Cancer Management and Research, Vol Volume 12, Pp 543-556 (2020)

Viviane Lamim Lovatel,1 Cecilia de Souza Fernandez,2 Eliane Ferreira Rodrigues,1 Rita de Cassia Tavares,3 Elaine Sobral da Costa,4 Eliana Abdelhay,5 Sheila Coelho Soares Lima,6 Teresa de Souza Fernandez1 1Cytogenetics Department, Bone Marrow Transpla

Externí odkaz: https://doaj.org/article/7fdd1c56f818464ca83f75861ecdbecb

KMT2A-MLLT1 and the Novel SEC16A-KMT2A in a Cryptic 3-Way Translocation t(9;11;19) Present in an Infant With Acute Lymphoblastic Leukemia.

Autor: de Matos RRC; Cytogenetics Department, Bone Marrow Transplantation Unit, Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA).; Post-Graduation Program in Oncology, National Cancer Institute (INCA)., Ferreira GM; Post-Graduation Program in Oncology, National Cancer Institute (INCA).; Stem Cell Department, Bone Marrow Transplantation Unit, Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA)., Meyer C; Institute of Pharmaceutical Biology, Diagnostic Center of Acute Leukemia, Goethe University Frankfurt, Frankfurt/Main., Marschalek R; Institute of Pharmaceutical Biology, Diagnostic Center of Acute Leukemia, Goethe University Frankfurt, Frankfurt/Main., Larghero P; Institute of Pharmaceutical Biology, Diagnostic Center of Acute Leukemia, Goethe University Frankfurt, Frankfurt/Main., Ribeiro RC; Departments of Oncology and Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN., Liehr T; Jena University Hospital, Friedrich Schiller University, Institute of Human Genetics, Jena, Germany., Othman M; Jena University Hospital, Friedrich Schiller University, Institute of Human Genetics, Jena, Germany., Bizarro MTSM; Cytogenetics Department, Bone Marrow Transplantation Unit, Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA)., Sobral da Costa E; Clinical Medicine Post-Graduation Program, Faculty of Medicine.; Pediatrics Institute IPPMG, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Land MGP; Clinical Medicine Post-Graduation Program, Faculty of Medicine.; Pediatrics Institute IPPMG, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Abdelhay E; Post-Graduation Program in Oncology, National Cancer Institute (INCA).; Stem Cell Department, Bone Marrow Transplantation Unit, Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA)., Binato R; Post-Graduation Program in Oncology, National Cancer Institute (INCA).; Stem Cell Department, Bone Marrow Transplantation Unit, Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA)., Silva MLM; Cytogenetics Department, Bone Marrow Transplantation Unit, Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA).; Post-Graduation Program in Oncology, National Cancer Institute (INCA).

Publikováno v: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2022 Apr 01; Vol. 44 (3), pp. e719-e722.

B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients.

Autor: Mendonça de Pontes R; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Cytometry Service, Institute of Paediatrics and Puericultura Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil., Flores-Montero J; Translational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain., Sanoja-Flores L; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Institute of Biomedicine of Seville, Department of Hematology, University Hospital Virgen del Rocío of the Consejo Superior de Investigaciones Científicas (CSIC), University of Seville, 41013 Seville, Spain., Puig N; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain., Pessoa de Magalhães RJ; Department of Internal Medicine, University Hospital Clementino Fraga Filho, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil., Corral-Mateos A; Translational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain., Salgado AB; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil., García-Sánchez O; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain., Pérez-Morán J; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain., Mateos MV; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain., Burgos L; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Clínica Universidad de Navarra, 31008 Pamplona, Spain., Paiva B; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Clínica Universidad de Navarra, 31008 Pamplona, Spain., Te Marvelde J; Department of Immunology, Erasmus MC, (EMC) University Medical Center Rotterdam, 3015 GA Rotterdam, The Netherlands., van der Velden VHJ; Department of Immunology, Erasmus MC, (EMC) University Medical Center Rotterdam, 3015 GA Rotterdam, The Netherlands., Aguilar C; Department of Hematology, Hospital General de Santa Bárbara, 42005 Soria, Spain., Bárez A; Department of Hematology, Complejo Asistencial de Ávila, 05071 Ávila, Spain., García-Mateo A; Department of Hematology, Complejo Asistencial de Segovia, 40002 Segovia, Spain., Labrador J; Department of Hematology and Research Unit, Hospital Universitario de Burgos, 09006 Burgos, Spain., Leoz P; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain., Aguilera-Sanz C; Department of Hematology, Hospital El Bierzo, 24404 Ponferrada, Spain., Durie B; Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA 90048, USA., van Dongen JJM; Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Maiolino A; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Department of Internal Medicine, University Hospital Clementino Fraga Filho, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Americas Centro de Oncologia Integrado, Rio de Janeiro 22290-030, Brazil., Sobral da Costa E; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Cytometry Service, Institute of Paediatrics and Puericultura Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil., Orfao A; Translational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.

Publikováno v: Cancers [Cancers (Basel)] 2021 Apr 03; Vol. 13 (7). Date of Electronic Publication: 2021 Apr 03.

Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry.

Autor: Ally, Feras¹ (AUTHOR) fally@uw.edu, Chen, Xueyan^1,2 (AUTHOR) xchen3@fredhutch.org

Publikováno v: Cancers. Nov2024, Vol. 16 Issue 22, p3855. 24p.

New insights into PSAT1 as a therapeutic target for myelodysplastic syndrome (MDS).

Autor: Alatawi, Sael¹ (AUTHOR) s.alatwi@ut.edu.sa, Alzamzami, Waseem¹ (AUTHOR)

Publikováno v: PLoS ONE. 8/26/2024, Vol. 19 Issue 8, p1-15. 15p.